These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 6393389

  • 1. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA, Collen D.
    Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract] [Full Text] [Related]

  • 2. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ, Francis CW.
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract] [Full Text] [Related]

  • 3. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
    [Abstract] [Full Text] [Related]

  • 4. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D, Lijnen HR.
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic advances against thromboembolic disease: II. The use of tissue fibrinolysis activator as a thrombolytic agent].
    Rueda F, Félez J.
    Sangre (Barc); 1984 Jul; 29(4-A):429-48. PubMed ID: 6390755
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA, Massumoto C, Fujimura AY, Pileggi F, Bellotti G.
    Rev Hosp Clin Fac Med Sao Paulo; 1989 Jul; 44(6):288-94. PubMed ID: 2518605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F.
    Z Gesamte Inn Med; 1984 May 15; 39(10):209-13. PubMed ID: 6380126
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Streptokinase or urokinase: the elements of choice].
    Pâques EP.
    Haemostasis; 1986 Jun 30; 16 Suppl 4():21-5. PubMed ID: 2429902
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.